Olanzapine-induced diabetes in a seven-year-old boy

Journal of Child and Adolescent Psychopharmacology

Volumn 14, Issue 4, 2005, Pages 612-616

  Courvoisie, Helen E ^a   Cooke, David W ^b   Riddle, Mark A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; GUANFACINE; KETONE; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROIC ACID;

ARTICLE; BODY WEIGHT DISORDER; CASE REPORT; DIABETES MELLITUS; DIAGNOSTIC VALUE; DRUG WITHDRAWAL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; KETOACIDOSIS; KETONURIA; LABORATORY DIAGNOSIS; MALE; PATIENT MONITORING; PSYCHOSIS; RECURRENCE RISK; SCHOOL CHILD; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; CHILD; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; RECURRENCE;

EID: 12744277938     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2004.14.612     Document Type: Article

References (21)

1. Bettinger TL, Mendelson SC, Dorson PG, Crismon ML: Olanzapine-induced glucose dysregulation. Ann Pharmacother 34:865-867, 2000.
2. Courvoisie HE, Koo HM, Horrigan JP, Barnhill LJ: A review of weight gain in a pediatric population treated with atypical antipsychotics. Poster presented at NCDEU, 2001.
3. Domon SE, Webber JC: Hyperglycemia and hypertriglyceridemia secondary to olanzapine. J Child Adolesc Psychopharmacol 11:285-288, 2001.
4. Haapasalo-Pesu KM, Saarijarvi S: Olanzapine induces remarkable weight gain in adolescent patients. Eur Child Adolesc Psychiatry 10:205-208, 2001.
5. Kelly DL, Conley RR, Love RC, Horn DS, Uschak CM: Weight gain in adolescents treated with risperidone and conventional antipsychotics over 6 months. J Child Adolesc Psychopharmol 8:151-159, 1998.
6. Koch-Wesser J, Browne TR: Drug therapy: Valproic acid. N Engl J Med 302:661-666, 1980.
7. Liebzeit KA, Markowitz JS, Caley CF: New onset diabetes and atypical antipsychotics. Eur Neuropsychopharmacol 11:25-32, 2001.
8. Lindenmayer JP, Nathan AM, Smith RC: Hyperglycemia associated with the use of atypical antipsychotics. J Clin Psychiatry 62 (Supp 23): 30-38, 2001.
9. Martin A, Landau J, Leebens P, Ulizio K, Cicchetti D, Scahill L, Leckman JF: Risperidone-associated weight gain in children and adolescents: A retrospective chart review. J Child Adolesc Psychopharmacol 10:259-268, 2000.
10. Melkersson KI, Hulting AL: Insulin and leptin levels in patients with schizophrenia or related psychoses - a comparison between different antipsychotic agents. Psychopharmacology (Berl) 154:205-212, 2001.
11. Melkersson KI, Hulting AL, Brismar KE: Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 61:742-749, 2000.
12. Meyer JM: A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year. J Clin Psychiatry 63:425-433, 2002.
13. Mir S, Taylor D: Atypical antipsychotics and hyperglycaemia. Int Clin Psychopharmacol 16:63-73, 2001.
14. Ratzoni G, Gothelf D, Brand-Gothelf A, Reidman J, Kikinzon L, Gal G, Phillip M, Apter A, Weizman R: Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study J Am Child Adolesc Psychiatry 41:337-343, 2002.
15. Rigalleau V, Gatta B, Bonnaud S, Masson M, Bourgeois ML, Vergnot V, Gin H. Diabetes as a result of atypical anti-psychotic drugs - a report of three cases. Diabet Med 17:484-486, 2000.
16. Selva KA, Scott SM: Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J Pediatr 138:36-38, 2001.
17. Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 159:561-566, 2002.
18. Taylor DM, McAskill R: Atypical antipsychotics and weight gain - a systematic review. Acta Psychiatr Scand 101:416-432, 2000.
19. Wetterling T: Bodyweight gain with atypical antipsychotics. A comparative review. Drug Saf 24:59-73, 2001.
20. Wirshing DA, Pierre JM, Eyeler J, Weinbach J, Wirshing WC: Risperidone-associated new-onset diabetes. Biol Psychiatry 50:148-149, 2001.
21. Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC: Novel antipsychotics and new-onset diabetes. Biol Psychiatry 44:778-783, 1998.